Check out what we have in store for you in the October Newsletter
As the election draws near, it is important that everyone, regardless of political leanings, register and vote in your local, state and national election. This election is probably the most important election of our lifetime and the outcome will affect almost every area of our lives for years to come including hepatitis C healthcare, treatment, and drug therapy.
This month’s newsletter is packed with important information that everyone with hepatitis C should review:
- HCV Drugs by Alan Franciscus – I reviewed two studies: The first study is about the final results of the treatment of Odalasvir plus AL-335 with and without simeprevir to treat HCV genotype 1 treatment naïve patients for 6 or 8 weeks. The second review is the mind-boggling outcomes of a study that used a 2-day response guided protocol to treat people for 3 weeks that produced 100% cure rates.
- Snapshots by Alan Franciscus—I reviewed two studies: The first one is a study conducted in the Veterans Affairs National Health Care System that evaluated all of the current (at that time) direct-acting antivirals (DAAs) medications to understand the cure rates and the ‘real-world’ results vs. results from the clinical trials.
- HealthWise – How I Nearly Outed Someone’s Hepatitis C Status: A Cautionary Tale by Lucinda K. Porter, RN—Lucinda discusses privacy issues that we are all concerned about in the age of Facebook, Twitter, and the other social media/internet and how to combat privacy issues and stigma.
- Under the Umbrella—No Man is an Island: Part 2, Hepatitis C in Rural Southern Indiana—Matthew continues his saga about HCV with an emphasis on jails and prisons including what can be done to provide education and support to improve the health outcomes of inmates living with hepatitis C and therefore the entire community of hepatitis C.
- Monthly Drug Pipeline has been updated with a link to the article about the Janssen story in this month’s HCV Advocate.
- What’s Up!
- We have reviewed and updated our entire HBV Treatment Fact Sheet Series!
- Don’t forget to check out our HCV Advocate Clinical Trials Reference Guide – we only include clinical trials that are actively recruiting patients and we are constantly adding content.
- Vote.USA.gov provides information by state on the requirements to register to vote and how to apply to vote.